Eyecheck, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study to Reinforce Immunity (STRI) Phase 2 Clinical Trial (NCT05046561) | Eyecheck, Inc. | 2021-11-04 |
Track Eyecheck, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.